6,436
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021

, , , , &
Article: 2160196 | Received 26 Oct 2022, Accepted 11 Dec 2022, Published online: 20 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Massimo Travaglini, Julia-Tatjana Maul, Christian Kors, Shirin Zaheri, Jens Gerwien, Michaela Müller, Alan Brnabic, Silvia Sabatino, Christopher Schuster & Tsen-Fang Tsai. (2023) Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO). Clinical, Cosmetic and Investigational Dermatology 16, pages 2971-2983.
Read now
Andrea Chiricozzi, Matteo Megna, Alessandro Giunta, Carlo Giovanni Carrera, Paolo Dapavo, Anna Balato, Piergiorgio Malagoli, Stella Mazzoccoli, Aurora Parodi, Silvia Sabatino, Carlotta Buzzoni, Chu-Han Huang & Alessandra Narcisi. (2023) Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study). Journal of Dermatological Treatment 34:1.
Read now
Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now

Articles from other publishers (2)

Beatriz Joven, Concepción Fito Manteca, Esteban Rubio, Enrique Raya, Alba Pérez, Raquel Hernández, Sara Manrique, Mercedes Núñez, Silvia Díaz-Cerezo, Sebastián Moyano, Alessandra Lacetera & Rosario García-Vicuña. (2023) Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study. Advances in Therapy 40:12, pages 5415-5431.
Crossref
Min Zheng, Xiang Chen, Feng Wang, Jisu Chen, Kimberley Jackson, Fan Yang, Christopher Payne, HongYing Li, YiHui Wang, ZiPei Xiao & Jie Zheng. (2023) Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study. Advances in Therapy 40:9, pages 3804-3816.
Crossref